Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PoseidonDCM: Autologous vs Allogeneic MSCs in Non-ischemic Dilated Cardiomyopathy
NCT01392625Phase 2Completed
- Start
- May 2011
- Primary completion
- Aug 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous bone marrow-derived mesenchymal stromal cells in dilated cardiomyopathy (DCM). Started May 2011; status: completed.
02
Drugs
autologous bone marrow-derived mesenchymal stromal cells
03
Conditions
dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT01392625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01392625.